4don MSN
After a heart attack, beta-blockers are often a lifelong medicine. Maybe they shouldn’t be
For decades, surviving a heart attack has come with a lifelong prescription: Stay on medications called beta-blockers to help protect your heart. But doctors are taking a closer look at whether ...
The results run counter to ABYSS but align with other data showing beta-blockers shouldn’t continue indefinitely after MI.
Hosted on MSN
Beta-Blocker Dos and Don’ts
If you have an abnormal heart rhythm or another heart condition like high blood pressure, a beta-blocker may be a key part of your treatment plan. Beta-blockers, such as atenolol, metoprolol, and ...
MedPage Today on MSN
Drop the beta-blocker long after a stabilized MI? Not a bad idea after all
Trial assessed outcomes of quitting therapy after 1 year among select MI survivors ...
Credit: Getty Images A discussion of the use of beta-blocker therapy following AMI, with Christopher Granger, MD, Gregg Fonarow, MD, and Carlin S Long, MD. Beta blockers have long been included in the ...
Add Yahoo as a preferred source to see more of our stories on Google. A large new study conducted in Spain and Italy found that beta blockers, drugs often used to slow the heart rate and lower blood ...
A common heart attack pill may not be helpful for some heart conditions, according to new research. Bibek Raj Giri/Getty Images Beta-blockers are a common group of medications that help manage several ...
Patients (N = 4,192) younger than 65 years with HNSCC, NSCLC, melanoma, or skin SCC treated at MD Anderson Cancer Center from 2010 to 2021 were included. Overall survival (OS), disease-specific ...
Please provide your email address to receive an email when new articles are posted on . Use of beta-blockers was associated with a reduced likelihood of patients undergoing TKA for OA. Use of ...
Please provide your email address to receive an email when new articles are posted on . Patients who used a beta-blocker with Simbrinza had significantly delayed allergy onset, which may boost ...
Seena Fazel of the University of Oxford, UK, and colleagues at the Karolinska Institute in Sweden compared the medicated and non-medicated periods of over 1.4 million beta blocker users. The use of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results